Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Eng

Showing results (11-20 of 315) with videos related to

Pageof 32
Sort By:
The Lancet. Oncology|January 31, 2020
TAS-102 plus bevacizumab: a new standard for metastatic colorectal cancer?Cathy Eng
Clinical Advances in Hematology & Oncology : H&O|March 15, 2022
Examining the increase in colorectal cancer in younger patientsCathy Eng
Science Translational Medicine|August 20, 2010
Are herbal medicines ripe for the cancer clinic?Cathy Eng
The Lancet. Oncology|June 4, 2013
Will PICCOLO affect metastatic colorectal cancer therapy?Cathy Eng
Clinical Advances in Hematology & Oncology : H&O|January 10, 2018
The promise of immunotherapy in anal squamous cell carcinoma: a novel approach for an orphan diseaseBenny Johnson, Cathy Eng
Surgical Oncology Clinics of North America|November 28, 2016
Metastatic Anal Cancer and Novel AgentsVan Morris, Cathy Eng
Clinics in Colon and Rectal Surgery|November 30, 2017
Neoadjuvant Strategies: Locally Advanced Rectal CancerShahab Ahmed, Cathy Eng
Journal of Gastrointestinal Oncology|October 18, 2016
Summary of emerging targets in anal cancer: the case for an immunotherapy based-approachVan Morris, Cathy Eng
Expert Review of Anticancer Therapy|July 2, 2014
Optimal management of squamous cell carcinoma of the anal canal: where are we now?Cathy Eng, Shahab Ahmed
Nature Reviews. Clinical Oncology|August 10, 2011
The current landscape of locally advanced rectal cancerMebea Aklilu, Cathy Eng
Pageof 32

Showing results (11-20 of 315) with videos related to

Sort By:
Pageof 32
The Lancet. Oncology|January 31, 2020
TAS-102 plus bevacizumab: a new standard for metastatic colorectal cancer?Cathy Eng
Clinical Advances in Hematology & Oncology : H&O|March 15, 2022
Examining the increase in colorectal cancer in younger patientsCathy Eng
Science Translational Medicine|August 20, 2010
Are herbal medicines ripe for the cancer clinic?Cathy Eng
The Lancet. Oncology|June 4, 2013
Will PICCOLO affect metastatic colorectal cancer therapy?Cathy Eng
Clinical Advances in Hematology & Oncology : H&O|January 10, 2018
The promise of immunotherapy in anal squamous cell carcinoma: a novel approach for an orphan diseaseBenny Johnson, Cathy Eng
Surgical Oncology Clinics of North America|November 28, 2016
Metastatic Anal Cancer and Novel AgentsVan Morris, Cathy Eng
Clinics in Colon and Rectal Surgery|November 30, 2017
Neoadjuvant Strategies: Locally Advanced Rectal CancerShahab Ahmed, Cathy Eng
Journal of Gastrointestinal Oncology|October 18, 2016
Summary of emerging targets in anal cancer: the case for an immunotherapy based-approachVan Morris, Cathy Eng
Expert Review of Anticancer Therapy|July 2, 2014
Optimal management of squamous cell carcinoma of the anal canal: where are we now?Cathy Eng, Shahab Ahmed
Nature Reviews. Clinical Oncology|August 10, 2011
The current landscape of locally advanced rectal cancerMebea Aklilu, Cathy Eng
Pageof 32